EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model (Q39652489)

13 September 2017

title

EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model (English)

1 reference

13 September 2017

1 reference

Xia Ke

1

1 reference

13 September 2017

Yu-cheng Yang

series ordinal

2

1 reference

13 September 2017

Su-ling Hong

series ordinal

3

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20862567

18 July 2024

publication date

24 September 2010

1 reference

full work available at URL

13 September 2017

http://link.springer.com/content/pdf/10.1007/s12032-010-9681-2.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S12032-010-9681-2

http://link.springer.com/article/10.1007/s12032-010-9681-2/fulltext.html

18 July 2024

1 reference

https://api.crossref.org/works/10.1007/S12032-010-9681-2

http://link.springer.com/content/pdf/10.1007/s12032-010-9681-2

18 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S12032-010-9681-2

18 July 2024

1 reference

13 September 2017

volume

28 Suppl 1

1 reference

13 September 2017

page(s)

S326-32

1 reference

Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Nasopharyngeal carcinomas: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

DNAzyme technology and cancer therapy: cleave and let die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Specific repression of mutant K-RAS by 10-23 DNAzyme: sensitizing cancer cell to anti-cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Suppression of platelet-type 12-lipoxygenase activity in human erythroleukemia cells by an RNA-cleaving DNAzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Effect of DNAzymes targeting Akt1 on cell proliferation and apoptosis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9681-2

Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.

21 January 2018

1 reference

12 December 2020

Design of efficient DNAzymes against muscle AChR alpha-subunit cRNA in vitro and in HEK 293 cells.

1 reference

12 December 2020

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

12 December 2020

DNAzymes as potential therapeutic molecules.

1 reference

12 December 2020

Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1

1 reference

12 December 2020

Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines

1 reference

12 December 2020

Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells.

1 reference

12 December 2020

Nasopharyngeal carcinoma

1 reference

12 December 2020

Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.

1 reference

12 December 2020

Identifiers

DOI

1 reference

13 September 2017

1 reference